Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

What are taxpayers spending for those ‘free’ covid tests? The government won’t say.

The four free covid-19 rapid tests President Joe Biden promised in December for every American household have begun arriving in earnest in mailboxes and on doorsteps.

11 Feb 2022

Showcasing STEM Women in Medical Science

Every year, the UN celebrates the International Day of Women and Girls in Science. For 2022, the focus is placed on recognizing the role women and girls play in STEM as beneficiaries and as agents of change.

11 Feb 2022

Exits by Black and Hispanic teachers pose a new threat to covid-era education

Lynette Henley needed one more year to receive her full pension after 40 years as a teacher, but she couldn't convince herself it was worth the risk.

11 Feb 2022

Study investigates population immunity to SARS-CoV-2 through heterogenous pathways

A new study demonstrates COVID-19 vaccine-specific differences in the antibody responses and memory B-cell immunity in a sample population comprising of 197 vaccinated individuals in Mexico.

11 Feb 2022

Survey demonstrates financial and mental health damage that may outlive the COVID threat

New Yorkers entering their third year of COVID have bleak views of the near-term economy and a strong conviction that vaccines should be required for those seeking to participate in their city's indoor activities (69%), to work in its service industries (66%) or schools (69%), and even to travel on airplanes (68%).

11 Feb 2022

Novel molecule shows ability to inhibit the replication of all coronaviruses

Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into a drug suitable for treating COVID-19.

10 Feb 2022

Case study: COVID-19 preventive behaviors impacted by implicit social pressure, desire for normalcy

As we move into the third year of the COVID-pandemic, we still face a multitude of information and it can be hard to know what guidelines to follow.

10 Feb 2022

Michigan residents experienced increased disabilities following COVID-19 illness

Michigan residents who were sick with COVID-19 in 2020 were almost twice as likely to experience disability following their illness, according to the latest report from the Michigan COVID-19 Recovery Surveillance Study.

10 Feb 2022

Unavailability of COVID-19 testing linked to greater intentions to engage in risky behavior

A research survey of more than 1,100 people in the United States found that when COVID-19 testing wasn't available in their community, participants showed significantly greater intentions to engage in risky behavior, possibly leading to increased transmission of the virus.

10 Feb 2022

KHN’s ‘What the Health?’: FDA takes center stage

The FDA is still lacking a Senate-confirmed leader, but the agency is at the center of several major policy battles. Lawmakers this year must renew the bill that authorizes drug companies to pay "user fees," which enable the agency to hire additional reviewers to speed the approval of drugs.

10 Feb 2022

Study suggests SARS-CoV-2 Omicron showed increased household transmission and immune evasion in Norway

Researchers from Norway used contact tracing data to measure and compare the household secondary attack rate of the SARS-CoV-2 Omicron and Delta variants at a time of prominence of both variants in the country.

10 Feb 2022

Study reports accumulation of SARS-CoV-2 RNA in sewer biofilms

During the COVID-19 pandemic, monitoring the levels of SARS-CoV-2 RNA in wastewater entering treatment plants has been one way that researchers have gauged the disease's spread.

10 Feb 2022

Analysis reveals the prevalence of loneliness at a problematic level in 113 countries

Loneliness at a problematic level is widespread in many countries, finds an analysis of evidence from 113 countries and territories during 2000-19 published by The BMJ today.

10 Feb 2022

Excess COVID-19 mortality in Eastern Europe linked to lower vaccination rates and weak implementation of regulations

Researchers assessed the association between excess COVID-19 mortalities with vaccination rate, and regulation enforcement, in Eastern European countries that witnessed high COVID-19 mortalities throughout 2021.

10 Feb 2022

Screening assays identify TMPRSS2 inhibitors from drug repurposing candidates useful as COVID-19 therapeutic

Researchers used an assay toolset for discovering new transmembrane protease serine 2 inhibiting drug repurposing candidates, that can be useful as therapeutics for COVID-19 treatment.

10 Feb 2022

Clinical severity of COVID-19 caused by SARS-CoV-2 variants and the effectiveness of mRNA vaccines against them

A recent study examined the clinical severity of the SARS-CoV-2 Alpha, Delta, and Omicron VOCs and compared vaccine effectiveness against each VOC.

10 Feb 2022

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine for COVID-19 are just as safe for people with cancer as they are for cancer-free individuals.

10 Feb 2022

Neutralizing antibody ABP-310 found to be highly potent against SARS-CoV-2 variants including Omicron

In a new study, a team of researchers described the efficacy of ABP-310, a neutralizing antibody, against SARS-CoV-2 variants, including Omicron.

10 Feb 2022

Study explores protection against Omicron and Delta infections by COVID-19 vaccination and previous infection

A new study demonstrated that infection- and vaccine-induced protection induced by the primary COVID-19 vaccination was much reduced for the Omicron BA.1 infection compared to the Delta infection.

10 Feb 2022

Protective efficacy of BNT162b2 and Ad26.COV2.S against SARS-CoV-2 Omicron challenge in nonhuman primates

The study highlights the significance of mix-and-match vaccine regimens to diversify the immune responses against highly mutated variants of SARS-CoV-2 such as Omicron.

10 Feb 2022

Pandemic News and Research

Further Reading

What are taxpayers spending for those ‘free’ covid tests? The government won’t say.

Showcasing STEM Women in Medical Science

Exits by Black and Hispanic teachers pose a new threat to covid-era education

Study investigates population immunity to SARS-CoV-2 through heterogenous pathways

Survey demonstrates financial and mental health damage that may outlive the COVID threat

Novel molecule shows ability to inhibit the replication of all coronaviruses

Case study: COVID-19 preventive behaviors impacted by implicit social pressure, desire for normalcy

Michigan residents experienced increased disabilities following COVID-19 illness

Unavailability of COVID-19 testing linked to greater intentions to engage in risky behavior

KHN’s ‘What the Health?’: FDA takes center stage

Study suggests SARS-CoV-2 Omicron showed increased household transmission and immune evasion in Norway

Study reports accumulation of SARS-CoV-2 RNA in sewer biofilms

Analysis reveals the prevalence of loneliness at a problematic level in 113 countries

Excess COVID-19 mortality in Eastern Europe linked to lower vaccination rates and weak implementation of regulations

Screening assays identify TMPRSS2 inhibitors from drug repurposing candidates useful as COVID-19 therapeutic

Clinical severity of COVID-19 caused by SARS-CoV-2 variants and the effectiveness of mRNA vaccines against them

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

Neutralizing antibody ABP-310 found to be highly potent against SARS-CoV-2 variants including Omicron

Study explores protection against Omicron and Delta infections by COVID-19 vaccination and previous infection

Protective efficacy of BNT162b2 and Ad26.COV2.S against SARS-CoV-2 Omicron challenge in nonhuman primates

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News